167 related articles for article (PubMed ID: 26131804)
1. Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights.
Haghighatafshar M; Farhoudi F
Medicine (Baltimore); 2015 Jul; 94(26):e1015. PubMed ID: 26131804
[TBL] [Abstract][Full Text] [Related]
2. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases.
Mello ME; Flamini RC; Corbo R; Mamede M
Arq Bras Endocrinol Metabol; 2009 Oct; 53(7):874-9. PubMed ID: 19942990
[TBL] [Abstract][Full Text] [Related]
4. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
[TBL] [Abstract][Full Text] [Related]
5. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma.
Salvatori M; Saletnich I; Rufini V; Troncone L
Clin Nucl Med; 1997 Jun; 22(6):380-4. PubMed ID: 9193808
[TBL] [Abstract][Full Text] [Related]
6. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
Abhyankar A; Basu S
J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of isotope diagnosis, ultrasound neck investigation and thyroglobulin assays in quantification of patients operated on for differentiated thyroid cancer and prepared for radioiodine treatment].
Manuszewska-Jopek E; Bolko P; Łacka K; Ruchała M; Oleksa R; Majewski P; Sowiński J
Pol Arch Med Wewn; 2003 Mar; 109(3):265-73. PubMed ID: 12924173
[TBL] [Abstract][Full Text] [Related]
8. Iodine concentration by the thymus in thyroid carcinoma.
Vermiglio F; Baudin E; Travagli JP; Caillou B; Fragu P; Ricard M; Schlumberger M
J Nucl Med; 1996 Nov; 37(11):1830-1. PubMed ID: 8917186
[TBL] [Abstract][Full Text] [Related]
9. Elevated iodine uptake at autogenous bone graft harvest sites.
Yang J; Codreanu I; Servaes S; Zhuang H
Clin Nucl Med; 2012 Sep; 37(9):901-3. PubMed ID: 22889785
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
[TBL] [Abstract][Full Text] [Related]
11. Is postablation whole-body
Liu B; Chen Y; Jiang L; He Y; Huang R; Kuang A
Clin Endocrinol (Oxf); 2017 Jan; 86(1):134-140. PubMed ID: 27434740
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic 123I Whole Body Scan Prior to Ablation of Thyroid Remnant in Patients With Papillary Thyroid Cancer: Implications for Clinical Management.
Song H; Mosci C; Akatsu H; Basina M; Dosiou C; Iagaru A
Clin Nucl Med; 2018 Oct; 43(10):705-709. PubMed ID: 30153149
[TBL] [Abstract][Full Text] [Related]
13. [Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Sun YG; Feng HJ; Liu JH; Hu R; Ouyang W
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1571-4. PubMed ID: 21945769
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of patients to detect recurrent thyroid carcinoma.
Grigsby PW; Baglan K; Siegel BA
Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
[TBL] [Abstract][Full Text] [Related]
15. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
16. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
17. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
19. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples.
McDougall IR
Clin Nucl Med; 1995 Oct; 20(10):869-75. PubMed ID: 8616989
[TBL] [Abstract][Full Text] [Related]
20. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
